Finally, we followed up a subset of patients for 4 weeks and beyond and observed no significant difference in the effect of COVID-19 patient sera on cardiomyocyte viability compared to vehicle controls, which despite not reaching significance was accompanied by an overall trend towards the proinflammatory cytokine response resolving (see Supplementary material online , Figure S8 ).
1
—
—